Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: ADHD is associated with several health outcomes, but its long-term cerebrovascular associations, particularly in adults with metabolic conditions, remain poorly understood.
Methods: A retrospective cohort analysis was performed using the Disease Analyzer database (IQVIA) and included adults with ADHD which were compared to a propensity score matched non-ADHD cohort. The 10-year incidence of acute ischemic stroke (AIS) or transient ischemic attack (TIA) was analyzed using Kaplan-Meier curves and univariable conditional Cox regression models with hazard ratios (HRs) and 99% confidence intervals (CIs).
Results: Among 8,943 ADHD patients and 44,660 controls, 1.7% of ADHD patients and 1.2% of controls experienced AIS or TIA (log-rank test, p = 0.006). In the regression analysis, there was a significant association between ADHD and subsequent TIA or AIS in the total population (HR: 1.69; 99% CI:1.13-2.51). This association was stronger and significant in subgroups of patients aged >45 years (HR: 2.34; 99% CI: 1.43-3.81) and those with obesity (HR: 1.86; 99% CI: 1.22-2.83), hypertension (HR: 2.18; 99% CI: 1.19-3.97), or dyslipidemia (HR: 2.89; 99% CI: 1.48-5.52).
Conclusion: ADHD in adults, particularly those over 45 years of age and those with metabolic comorbidities, is associated with an increased risk of cerebrovascular disease. Further research is needed to confirm these associations and to explore the underlying mechanisms.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366380 | PMC |
| http://dx.doi.org/10.1186/s12888-025-07246-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluating Telepsychiatric Assessment Satisfaction in Children and Adolescents With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder and Their Caregivers: Randomized Controlled Trial.
JMIR Pediatr Parent
September 2025
Center for the Promotion of Interdisciplinary Research in Medicine and Life Science, Keio University School of Medicine, Mori JP Tower F7, 1-3-1, Azabudai, Minato-ku, Tokyo, 160-0041, Japan, 81 353633219.
Background: Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) often face structural and psychological barriers in accessing medical care, including economic costs, long wait times, and stress of attending new medical environments. The COVID-19 pandemic accelerated the adoption of telehealth services to overcome these challenges. However, few studies have assessed the satisfaction levels of children and adolescents diagnosed with neurodevelopmental disorders and their caregivers when they use telepsychiatry, particularly in Japan.
View Article and Find Full Text PDFVitamin Interventions in ASD and ADHD: Systematic Review and Meta-Analysis.
Neuropsychiatr Dis Treat
August 2025
Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
Background: Vitamin interventions have emerged as a cost-effective and accessible approach to managing Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD), primarily for alleviating gastrointestinal symptoms such as constipation. Recent studies suggest vitamins may also improve core symptoms, yet most existing research focuses on comparisons between patients and healthy controls, lacking clinically relevant, evidence-based insights.
Methods: A meta-analysis was conducted using studies retrieved from PubMed, Web of Science, and the Cochrane Library, focusing on vitamin interventions in ASD and ADHD populations.
De Novo GLI2 Missense Variant in a Child With Isolated Hypopituitarism and Craniofacial Anomalies: Expanding the Phenotypic Spectrum.
Mol Genet Genomic Med
September 2025
Genomic Health, West Leederville, Western Australia, Australia.
Background: Culler-Jones syndrome (CJS) is an autosomal dominant disorder characterized by hypopituitarism, postaxial polydactyly, and craniofacial anomalies, associated with pathogenic GLI2 variants. Genotype-phenotype correlations suggest missense variants may present with isolated pituitary phenotypes.
Methods: We evaluated an 8-year-old boy referred for short stature, failure to thrive, and neurodevelopmental concerns.
The impact of methylphenidate on oral health parameters, salivary flow rate, and quality of life in children with attention-deficit/hyperactivity disorder: a cross-sectional study.
Clin Oral Investig
September 2025
Department of Pediatric Dentistry, School of Dentistry, Marmara University, Istanbul, Türkiye.
Objectives: This study aimed to evaluate and compare the effects of methylphenidate on oral health, salivary flow rate, and quality of life in children with Attention-Deficit/Hyperactivity Disorder (ADHD), focusing on differences between short-release methylphenidate (SRM) and long-release methylphenidate (LRM) formulations.
Materials And Methods: A total of 99 children participated in this cross-sectional study (ADHD: n = 49; divided into SRM (n = 27) and LRM (n = 22) subgroups based on medication type; control: n = 50). Dental caries was assessed using the DMFT/dft indices and the International Caries Detection and Assessment System (ICDAS), while oral hygiene was evaluated using the Plaque Index (PI), Gingival Index (GI), and Bleeding on Probing (BOP).
Clinical and Genetic Functional Validation of a Novel Mutation Causing MEDNIK Syndrome.
Int J Genomics
August 2025
Department of Hematology, The Affiliated Children's Hospital of Kunming Medical University, Kunming Medical University, Kunming, China.
MEDNIK syndrome is a rare copper metabolism disorder caused by variants. Herein, we report the clinical and genetic characteristics of MEDNIK syndrome in two siblings. The clinical treatment process for MEDNIK syndrome and over 4 years of follow-up data were analysed in two siblings.
View Article and Find Full Text PDF